Global Measles Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Measles Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Measles Vaccine industry chain, the market status of Children (Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)), Adults (Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Measles Vaccine.
Regionally, the report analyzes the Measles Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Measles Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Measles Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Measles Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Measles Vaccine market.
Regional Analysis: The report involves examining the Measles Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Measles Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Measles Vaccine:
Company Analysis: Report covers individual Measles Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Measles Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Children, Adults).
Technology Analysis: Report covers specific technologies relevant to Measles Vaccine. It assesses the current state, advancements, and potential future developments in Measles Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Measles Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Measles Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Measles Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measles Vaccine, with price, sales, revenue and global market share of Measles Vaccine from 2019 to 2024.
Chapter 3, the Measles Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Measles Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measles Vaccine.
Chapter 14 and 15, to describe Measles Vaccine sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Measles Vaccine industry chain, the market status of Children (Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)), Adults (Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Measles Vaccine.
Regionally, the report analyzes the Measles Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Measles Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Measles Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Measles Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Measles Vaccine market.
Regional Analysis: The report involves examining the Measles Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Measles Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Measles Vaccine:
Company Analysis: Report covers individual Measles Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Measles Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Children, Adults).
Technology Analysis: Report covers specific technologies relevant to Measles Vaccine. It assesses the current state, advancements, and potential future developments in Measles Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Measles Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Measles Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Mumps Measles Rubella Vaccine, Live (MMR-II)
- Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
- Children
- Adults
- GSK
- Sanofi-Pasteur
- Merck
- Novartis
- Pfizer
- Serum Institute of India
- China National Biotech Group
- Bavarian Nordic
- Emergent Biosolutions
- Medimmune
- Johnson & Johnson
- CSL Limited
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Measles Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Measles Vaccine, with price, sales, revenue and global market share of Measles Vaccine from 2019 to 2024.
Chapter 3, the Measles Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Measles Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Measles Vaccine.
Chapter 14 and 15, to describe Measles Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Measles Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measles Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.3.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.4 Market Analysis by Application
1.4.1 Overview: Global Measles Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Children
1.4.3 Adults
1.5 Global Measles Vaccine Market Size & Forecast
1.5.1 Global Measles Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Measles Vaccine Sales Quantity (2019-2030)
1.5.3 Global Measles Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Measles Vaccine Product and Services
2.1.4 GSK Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Measles Vaccine Product and Services
2.2.4 Sanofi-Pasteur Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi-Pasteur Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Measles Vaccine Product and Services
2.3.4 Merck Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Measles Vaccine Product and Services
2.4.4 Novartis Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Measles Vaccine Product and Services
2.5.4 Pfizer Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments/Updates
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Measles Vaccine Product and Services
2.6.4 Serum Institute of India Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Serum Institute of India Recent Developments/Updates
2.7 China National Biotech Group
2.7.1 China National Biotech Group Details
2.7.2 China National Biotech Group Major Business
2.7.3 China National Biotech Group Measles Vaccine Product and Services
2.7.4 China National Biotech Group Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 China National Biotech Group Recent Developments/Updates
2.8 Bavarian Nordic
2.8.1 Bavarian Nordic Details
2.8.2 Bavarian Nordic Major Business
2.8.3 Bavarian Nordic Measles Vaccine Product and Services
2.8.4 Bavarian Nordic Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bavarian Nordic Recent Developments/Updates
2.9 Emergent Biosolutions
2.9.1 Emergent Biosolutions Details
2.9.2 Emergent Biosolutions Major Business
2.9.3 Emergent Biosolutions Measles Vaccine Product and Services
2.9.4 Emergent Biosolutions Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Emergent Biosolutions Recent Developments/Updates
2.10 Medimmune
2.10.1 Medimmune Details
2.10.2 Medimmune Major Business
2.10.3 Medimmune Measles Vaccine Product and Services
2.10.4 Medimmune Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Medimmune Recent Developments/Updates
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Measles Vaccine Product and Services
2.11.4 Johnson & Johnson Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Johnson & Johnson Recent Developments/Updates
2.12 CSL Limited
2.12.1 CSL Limited Details
2.12.2 CSL Limited Major Business
2.12.3 CSL Limited Measles Vaccine Product and Services
2.12.4 CSL Limited Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 CSL Limited Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEASLES VACCINE BY MANUFACTURER
3.1 Global Measles Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Measles Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Measles Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Measles Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Measles Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Measles Vaccine Manufacturer Market Share in 2023
3.5 Measles Vaccine Market: Overall Company Footprint Analysis
3.5.1 Measles Vaccine Market: Region Footprint
3.5.2 Measles Vaccine Market: Company Product Type Footprint
3.5.3 Measles Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Measles Vaccine Market Size by Region
4.1.1 Global Measles Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Measles Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Measles Vaccine Average Price by Region (2019-2030)
4.2 North America Measles Vaccine Consumption Value (2019-2030)
4.3 Europe Measles Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Measles Vaccine Consumption Value (2019-2030)
4.5 South America Measles Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Measles Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Measles Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Measles Vaccine Consumption Value by Type (2019-2030)
5.3 Global Measles Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Measles Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Measles Vaccine Consumption Value by Application (2019-2030)
6.3 Global Measles Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Measles Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Measles Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Measles Vaccine Market Size by Country
7.3.1 North America Measles Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Measles Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Measles Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Measles Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Measles Vaccine Market Size by Country
8.3.1 Europe Measles Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Measles Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Measles Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Measles Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Measles Vaccine Market Size by Region
9.3.1 Asia-Pacific Measles Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Measles Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Measles Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Measles Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Measles Vaccine Market Size by Country
10.3.1 South America Measles Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Measles Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Measles Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Measles Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Measles Vaccine Market Size by Country
11.3.1 Middle East & Africa Measles Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Measles Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Measles Vaccine Market Drivers
12.2 Measles Vaccine Market Restraints
12.3 Measles Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Measles Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measles Vaccine
13.3 Measles Vaccine Production Process
13.4 Measles Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measles Vaccine Typical Distributors
14.3 Measles Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Measles Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Measles Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.3.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.4 Market Analysis by Application
1.4.1 Overview: Global Measles Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Children
1.4.3 Adults
1.5 Global Measles Vaccine Market Size & Forecast
1.5.1 Global Measles Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Measles Vaccine Sales Quantity (2019-2030)
1.5.3 Global Measles Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Measles Vaccine Product and Services
2.1.4 GSK Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GSK Recent Developments/Updates
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Measles Vaccine Product and Services
2.2.4 Sanofi-Pasteur Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi-Pasteur Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Measles Vaccine Product and Services
2.3.4 Merck Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Measles Vaccine Product and Services
2.4.4 Novartis Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Measles Vaccine Product and Services
2.5.4 Pfizer Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments/Updates
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Measles Vaccine Product and Services
2.6.4 Serum Institute of India Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Serum Institute of India Recent Developments/Updates
2.7 China National Biotech Group
2.7.1 China National Biotech Group Details
2.7.2 China National Biotech Group Major Business
2.7.3 China National Biotech Group Measles Vaccine Product and Services
2.7.4 China National Biotech Group Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 China National Biotech Group Recent Developments/Updates
2.8 Bavarian Nordic
2.8.1 Bavarian Nordic Details
2.8.2 Bavarian Nordic Major Business
2.8.3 Bavarian Nordic Measles Vaccine Product and Services
2.8.4 Bavarian Nordic Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bavarian Nordic Recent Developments/Updates
2.9 Emergent Biosolutions
2.9.1 Emergent Biosolutions Details
2.9.2 Emergent Biosolutions Major Business
2.9.3 Emergent Biosolutions Measles Vaccine Product and Services
2.9.4 Emergent Biosolutions Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Emergent Biosolutions Recent Developments/Updates
2.10 Medimmune
2.10.1 Medimmune Details
2.10.2 Medimmune Major Business
2.10.3 Medimmune Measles Vaccine Product and Services
2.10.4 Medimmune Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Medimmune Recent Developments/Updates
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Measles Vaccine Product and Services
2.11.4 Johnson & Johnson Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Johnson & Johnson Recent Developments/Updates
2.12 CSL Limited
2.12.1 CSL Limited Details
2.12.2 CSL Limited Major Business
2.12.3 CSL Limited Measles Vaccine Product and Services
2.12.4 CSL Limited Measles Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 CSL Limited Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MEASLES VACCINE BY MANUFACTURER
3.1 Global Measles Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Measles Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Measles Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Measles Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Measles Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Measles Vaccine Manufacturer Market Share in 2023
3.5 Measles Vaccine Market: Overall Company Footprint Analysis
3.5.1 Measles Vaccine Market: Region Footprint
3.5.2 Measles Vaccine Market: Company Product Type Footprint
3.5.3 Measles Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Measles Vaccine Market Size by Region
4.1.1 Global Measles Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Measles Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Measles Vaccine Average Price by Region (2019-2030)
4.2 North America Measles Vaccine Consumption Value (2019-2030)
4.3 Europe Measles Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Measles Vaccine Consumption Value (2019-2030)
4.5 South America Measles Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Measles Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Measles Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Measles Vaccine Consumption Value by Type (2019-2030)
5.3 Global Measles Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Measles Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Measles Vaccine Consumption Value by Application (2019-2030)
6.3 Global Measles Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Measles Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Measles Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Measles Vaccine Market Size by Country
7.3.1 North America Measles Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Measles Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Measles Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Measles Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Measles Vaccine Market Size by Country
8.3.1 Europe Measles Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Measles Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Measles Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Measles Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Measles Vaccine Market Size by Region
9.3.1 Asia-Pacific Measles Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Measles Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Measles Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Measles Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Measles Vaccine Market Size by Country
10.3.1 South America Measles Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Measles Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Measles Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Measles Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Measles Vaccine Market Size by Country
11.3.1 Middle East & Africa Measles Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Measles Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Measles Vaccine Market Drivers
12.2 Measles Vaccine Market Restraints
12.3 Measles Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Measles Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Measles Vaccine
13.3 Measles Vaccine Production Process
13.4 Measles Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Measles Vaccine Typical Distributors
14.3 Measles Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Measles Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Measles Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Measles Vaccine Product and Services
Table 6. GSK Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Pasteur Major Business
Table 10. Sanofi-Pasteur Measles Vaccine Product and Services
Table 11. Sanofi-Pasteur Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi-Pasteur Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Measles Vaccine Product and Services
Table 16. Merck Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Measles Vaccine Product and Services
Table 21. Novartis Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Novartis Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Measles Vaccine Product and Services
Table 26. Pfizer Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer Recent Developments/Updates
Table 28. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 29. Serum Institute of India Major Business
Table 30. Serum Institute of India Measles Vaccine Product and Services
Table 31. Serum Institute of India Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Serum Institute of India Recent Developments/Updates
Table 33. China National Biotech Group Basic Information, Manufacturing Base and Competitors
Table 34. China National Biotech Group Major Business
Table 35. China National Biotech Group Measles Vaccine Product and Services
Table 36. China National Biotech Group Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. China National Biotech Group Recent Developments/Updates
Table 38. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 39. Bavarian Nordic Major Business
Table 40. Bavarian Nordic Measles Vaccine Product and Services
Table 41. Bavarian Nordic Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bavarian Nordic Recent Developments/Updates
Table 43. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 44. Emergent Biosolutions Major Business
Table 45. Emergent Biosolutions Measles Vaccine Product and Services
Table 46. Emergent Biosolutions Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Emergent Biosolutions Recent Developments/Updates
Table 48. Medimmune Basic Information, Manufacturing Base and Competitors
Table 49. Medimmune Major Business
Table 50. Medimmune Measles Vaccine Product and Services
Table 51. Medimmune Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Medimmune Recent Developments/Updates
Table 53. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 54. Johnson & Johnson Major Business
Table 55. Johnson & Johnson Measles Vaccine Product and Services
Table 56. Johnson & Johnson Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Johnson & Johnson Recent Developments/Updates
Table 58. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 59. CSL Limited Major Business
Table 60. CSL Limited Measles Vaccine Product and Services
Table 61. CSL Limited Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. CSL Limited Recent Developments/Updates
Table 63. Global Measles Vaccine Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 64. Global Measles Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Measles Vaccine Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 66. Market Position of Manufacturers in Measles Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Measles Vaccine Production Site of Key Manufacturer
Table 68. Measles Vaccine Market: Company Product Type Footprint
Table 69. Measles Vaccine Market: Company Product Application Footprint
Table 70. Measles Vaccine New Market Entrants and Barriers to Market Entry
Table 71. Measles Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Measles Vaccine Sales Quantity by Region (2019-2024) & (K MT)
Table 73. Global Measles Vaccine Sales Quantity by Region (2025-2030) & (K MT)
Table 74. Global Measles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Measles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Measles Vaccine Average Price by Region (2019-2024) & (USD/MT)
Table 77. Global Measles Vaccine Average Price by Region (2025-2030) & (USD/MT)
Table 78. Global Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Global Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Global Measles Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Measles Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Measles Vaccine Average Price by Type (2019-2024) & (USD/MT)
Table 83. Global Measles Vaccine Average Price by Type (2025-2030) & (USD/MT)
Table 84. Global Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 85. Global Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 86. Global Measles Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Measles Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Measles Vaccine Average Price by Application (2019-2024) & (USD/MT)
Table 89. Global Measles Vaccine Average Price by Application (2025-2030) & (USD/MT)
Table 90. North America Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 91. North America Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 92. North America Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 93. North America Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 94. North America Measles Vaccine Sales Quantity by Country (2019-2024) & (K MT)
Table 95. North America Measles Vaccine Sales Quantity by Country (2025-2030) & (K MT)
Table 96. North America Measles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Measles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 99. Europe Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 100. Europe Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 101. Europe Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 102. Europe Measles Vaccine Sales Quantity by Country (2019-2024) & (K MT)
Table 103. Europe Measles Vaccine Sales Quantity by Country (2025-2030) & (K MT)
Table 104. Europe Measles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Measles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 107. Asia-Pacific Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 108. Asia-Pacific Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Asia-Pacific Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Asia-Pacific Measles Vaccine Sales Quantity by Region (2019-2024) & (K MT)
Table 111. Asia-Pacific Measles Vaccine Sales Quantity by Region (2025-2030) & (K MT)
Table 112. Asia-Pacific Measles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Measles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 115. South America Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 116. South America Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 117. South America Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 118. South America Measles Vaccine Sales Quantity by Country (2019-2024) & (K MT)
Table 119. South America Measles Vaccine Sales Quantity by Country (2025-2030) & (K MT)
Table 120. South America Measles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Measles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 123. Middle East & Africa Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 124. Middle East & Africa Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 125. Middle East & Africa Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 126. Middle East & Africa Measles Vaccine Sales Quantity by Region (2019-2024) & (K MT)
Table 127. Middle East & Africa Measles Vaccine Sales Quantity by Region (2025-2030) & (K MT)
Table 128. Middle East & Africa Measles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Measles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Measles Vaccine Raw Material
Table 131. Key Manufacturers of Measles Vaccine Raw Materials
Table 132. Measles Vaccine Typical Distributors
Table 133. Measles Vaccine Typical Customers
Table 1. Global Measles Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Measles Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Measles Vaccine Product and Services
Table 6. GSK Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GSK Recent Developments/Updates
Table 8. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi-Pasteur Major Business
Table 10. Sanofi-Pasteur Measles Vaccine Product and Services
Table 11. Sanofi-Pasteur Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi-Pasteur Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Measles Vaccine Product and Services
Table 16. Merck Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Measles Vaccine Product and Services
Table 21. Novartis Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Novartis Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Measles Vaccine Product and Services
Table 26. Pfizer Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer Recent Developments/Updates
Table 28. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 29. Serum Institute of India Major Business
Table 30. Serum Institute of India Measles Vaccine Product and Services
Table 31. Serum Institute of India Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Serum Institute of India Recent Developments/Updates
Table 33. China National Biotech Group Basic Information, Manufacturing Base and Competitors
Table 34. China National Biotech Group Major Business
Table 35. China National Biotech Group Measles Vaccine Product and Services
Table 36. China National Biotech Group Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. China National Biotech Group Recent Developments/Updates
Table 38. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 39. Bavarian Nordic Major Business
Table 40. Bavarian Nordic Measles Vaccine Product and Services
Table 41. Bavarian Nordic Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bavarian Nordic Recent Developments/Updates
Table 43. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 44. Emergent Biosolutions Major Business
Table 45. Emergent Biosolutions Measles Vaccine Product and Services
Table 46. Emergent Biosolutions Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Emergent Biosolutions Recent Developments/Updates
Table 48. Medimmune Basic Information, Manufacturing Base and Competitors
Table 49. Medimmune Major Business
Table 50. Medimmune Measles Vaccine Product and Services
Table 51. Medimmune Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Medimmune Recent Developments/Updates
Table 53. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 54. Johnson & Johnson Major Business
Table 55. Johnson & Johnson Measles Vaccine Product and Services
Table 56. Johnson & Johnson Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Johnson & Johnson Recent Developments/Updates
Table 58. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 59. CSL Limited Major Business
Table 60. CSL Limited Measles Vaccine Product and Services
Table 61. CSL Limited Measles Vaccine Sales Quantity (K MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. CSL Limited Recent Developments/Updates
Table 63. Global Measles Vaccine Sales Quantity by Manufacturer (2019-2024) & (K MT)
Table 64. Global Measles Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Measles Vaccine Average Price by Manufacturer (2019-2024) & (USD/MT)
Table 66. Market Position of Manufacturers in Measles Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Measles Vaccine Production Site of Key Manufacturer
Table 68. Measles Vaccine Market: Company Product Type Footprint
Table 69. Measles Vaccine Market: Company Product Application Footprint
Table 70. Measles Vaccine New Market Entrants and Barriers to Market Entry
Table 71. Measles Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Measles Vaccine Sales Quantity by Region (2019-2024) & (K MT)
Table 73. Global Measles Vaccine Sales Quantity by Region (2025-2030) & (K MT)
Table 74. Global Measles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Measles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Measles Vaccine Average Price by Region (2019-2024) & (USD/MT)
Table 77. Global Measles Vaccine Average Price by Region (2025-2030) & (USD/MT)
Table 78. Global Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 79. Global Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 80. Global Measles Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Measles Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Measles Vaccine Average Price by Type (2019-2024) & (USD/MT)
Table 83. Global Measles Vaccine Average Price by Type (2025-2030) & (USD/MT)
Table 84. Global Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 85. Global Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 86. Global Measles Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Measles Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Measles Vaccine Average Price by Application (2019-2024) & (USD/MT)
Table 89. Global Measles Vaccine Average Price by Application (2025-2030) & (USD/MT)
Table 90. North America Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 91. North America Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 92. North America Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 93. North America Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 94. North America Measles Vaccine Sales Quantity by Country (2019-2024) & (K MT)
Table 95. North America Measles Vaccine Sales Quantity by Country (2025-2030) & (K MT)
Table 96. North America Measles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Measles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 99. Europe Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 100. Europe Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 101. Europe Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 102. Europe Measles Vaccine Sales Quantity by Country (2019-2024) & (K MT)
Table 103. Europe Measles Vaccine Sales Quantity by Country (2025-2030) & (K MT)
Table 104. Europe Measles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Measles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 107. Asia-Pacific Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 108. Asia-Pacific Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 109. Asia-Pacific Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 110. Asia-Pacific Measles Vaccine Sales Quantity by Region (2019-2024) & (K MT)
Table 111. Asia-Pacific Measles Vaccine Sales Quantity by Region (2025-2030) & (K MT)
Table 112. Asia-Pacific Measles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Measles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 115. South America Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 116. South America Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 117. South America Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 118. South America Measles Vaccine Sales Quantity by Country (2019-2024) & (K MT)
Table 119. South America Measles Vaccine Sales Quantity by Country (2025-2030) & (K MT)
Table 120. South America Measles Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Measles Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Measles Vaccine Sales Quantity by Type (2019-2024) & (K MT)
Table 123. Middle East & Africa Measles Vaccine Sales Quantity by Type (2025-2030) & (K MT)
Table 124. Middle East & Africa Measles Vaccine Sales Quantity by Application (2019-2024) & (K MT)
Table 125. Middle East & Africa Measles Vaccine Sales Quantity by Application (2025-2030) & (K MT)
Table 126. Middle East & Africa Measles Vaccine Sales Quantity by Region (2019-2024) & (K MT)
Table 127. Middle East & Africa Measles Vaccine Sales Quantity by Region (2025-2030) & (K MT)
Table 128. Middle East & Africa Measles Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Measles Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Measles Vaccine Raw Material
Table 131. Key Manufacturers of Measles Vaccine Raw Materials
Table 132. Measles Vaccine Typical Distributors
Table 133. Measles Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Measles Vaccine Picture
Figure 2. Global Measles Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Measles Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Mumps Measles Rubella Vaccine, Live (MMR-II) Examples
Figure 5. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Examples
Figure 6. Global Measles Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Measles Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Children Examples
Figure 9. Adults Examples
Figure 10. Global Measles Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Measles Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Measles Vaccine Sales Quantity (2019-2030) & (K MT)
Figure 13. Global Measles Vaccine Average Price (2019-2030) & (USD/MT)
Figure 14. Global Measles Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Measles Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Measles Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Measles Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Measles Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Measles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Measles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Measles Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Measles Vaccine Average Price by Type (2019-2030) & (USD/MT)
Figure 29. Global Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Measles Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Measles Vaccine Average Price by Application (2019-2030) & (USD/MT)
Figure 32. North America Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Measles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Measles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Measles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Measles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Measles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Measles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Measles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Measles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Measles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Measles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Measles Vaccine Market Drivers
Figure 73. Measles Vaccine Market Restraints
Figure 74. Measles Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Measles Vaccine in 2023
Figure 77. Manufacturing Process Analysis of Measles Vaccine
Figure 78. Measles Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Measles Vaccine Picture
Figure 2. Global Measles Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Measles Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Mumps Measles Rubella Vaccine, Live (MMR-II) Examples
Figure 5. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Examples
Figure 6. Global Measles Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Measles Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Children Examples
Figure 9. Adults Examples
Figure 10. Global Measles Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Measles Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Measles Vaccine Sales Quantity (2019-2030) & (K MT)
Figure 13. Global Measles Vaccine Average Price (2019-2030) & (USD/MT)
Figure 14. Global Measles Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Measles Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Measles Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Measles Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Measles Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Measles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Measles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Measles Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Measles Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Measles Vaccine Average Price by Type (2019-2030) & (USD/MT)
Figure 29. Global Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Measles Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Measles Vaccine Average Price by Application (2019-2030) & (USD/MT)
Figure 32. North America Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Measles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Measles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Measles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Measles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Measles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Measles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Measles Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Measles Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Measles Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Measles Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Measles Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Measles Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Measles Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Measles Vaccine Market Drivers
Figure 73. Measles Vaccine Market Restraints
Figure 74. Measles Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Measles Vaccine in 2023
Figure 77. Manufacturing Process Analysis of Measles Vaccine
Figure 78. Measles Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
